The Healthcare & Life Sciences sector in Spain is undergoing a period of transformation and sustained growth, establishing itself as one of the strategic pillars of the national economy. Spain has become the fourth-largest European country in public healthcare investment, with over €134 billion, making it an attractive destination for private capital.

The Spanish pharmaceutical industry generates over €23 billion in annual revenue and directly employs more than 54,000 people, in addition to another 210,000 indirect jobs.

This growth is driven by factors such as an aging population, the rise of chronic diseases, the digitalization of healthcare services, and the increasing demand for personalized care.

Telemedicine, artificial intelligence, and digital health are redefining the patient experience and the operational efficiency of the healthcare system.

However, the sector faces significant challenges, including a shortage of healthcare professionals, the need to adapt to regulatory changes, and the pressure to integrate sustainability across the entire value chain. Public-private collaboration and investment in innovation will be key to ensuring the system’s resilience and sustainability in the coming years.

At BDO, we support our clients in the sector throughout their transformation journey, providing strategic, financial, and technological solutions that help them anticipate change and seize opportunities in an ever-evolving environment.